• MustGrow has received the Idaho State Department of Agriculture approval to commence sales of TerraSante^TM, an organic biofertility product, in Idaho.
• Mustard-derived TerraSante^TM focuses on soil and soil microbiome health, nutrient/water use efficiencies, and plant yields.

Saskatoon, Saskatchewan--(Newsfile Corp. - July 31, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce receipt of the Idaho State Department of Agriculture registration approval for its mustard plant-based TerraSante^TM, an organic biofertility product. The Idaho organic certification is included under MustGrow's existing Organic OMRI Listed^® certifications in Oregon and Washington State.

Potatoes are Idaho's top crop with a total value of production of US$1.3 billion in 2023, up from US$1.2 billion in 2022. Idaho had 330,000 potato acres in 2023, up 12% from 2022. ⁽¹⁾

Idaho ranked #1 in the U.S. in five different agriculture commodities in 2021: potatoes, barley, alfalfa hay, peppermint oil and food trout. The state also ranked #2 in the U.S. in 2021 in sugar beets and hops; #4 in dry onions, spring wheat, and lentils, and #5 in dry edible beans, corn silage, and dry edible peas. According to USDA's National Agricultural Statistics Service, Idaho's total agricultural crop production in 2021 was US$3.3 billion. Prior to 2021, the total value of Idaho agriculture production had increased for four consecutive years. ⁽²⁾

TerraSante^TM for Soil and Ecological Health

MustGrow's soil amendment and biofertility development programs focus on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. Soil is a farmer's most valuable asset, and MustGrow's mustard plant-based technologies are being developed with the intention to improve not only the health of the soil, but also the surrounding ecological environment.

As an organic biofertilizer in soluble mixable form, TerraSante^TM contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially improving beneficial microbial activity and ensuring long-term sustainable soil health. These targeted micro-communities have been shown to work to improve nutrient availability, which can potentially increase plant vigor and yields, while reducing plant stress. TerraSante^TM has the potential to improve crop nutrient uptake and, hence, overall crop performance. There are no artificial additives or preservatives used during its manufacturing.

To learn more about TerraSante^TM, visit www.mustgrow.ca.

In May 2024, MustGrow announced receipt of the California Department of Food Agriculture registration approval for its organic biofertility product TerraSante^TM, and also organic certification from California's Organic Input Material (OIM) Program, a specific California requirement beyond MustGrow's existing Organic OMRI Listed^® certifications in Oregon and Washington State. MustGrow's California registration and organic certification is a key pillar in the commercialization strategy with BioAg Product Strategies. In addition to Idaho, and recently-awarded California, Oregon and Washington State, MustGrow expects to continue its efforts towards further state-level registrations in other pertinent U.S. states.

About MustGrow

MustGrow is an agriculture biotech company developing organic biocontrol and biofertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply and help farmers feed the world. MustGrow and its leading global partners -- Bayer, Janssen PMP (pharmaceutical division of Johnson & Johnson), Sumitomo Corporation, and Univar Solutions' NexusBioAg -- are developing mustard-based organic solutions for applications in biocontrol to potentially replace harmful synthetic chemicals in preplant soil treatment and weed control, to postharvest disease control and food preservation. Bayer has a commercial agreement to develop and commercialize MustGrow's biocontrol soil applications in Europe, Africa, and the Middle East. Concurrently, with new formulations derived from food-grade mustard, the Company is pursuing the adoption and use of its Organic Materials Review Institute (OMRI Listed^®) and California's Organic Input Material (OIM) Program registered biofertility product, TerraSante^TM, in key U.S. states including California. Over 150 independent tests have been completed, validating MustGrow's safe and effective approach to crop and food protection and yield enhancements. Pending regulatory approval, MustGrow's patented liquid technologies could be applied through injection, standard drip or spray equipment, improving functionality and performance features. MustGrow has approximately 51.6 million basic common shares issued and outstanding and 54.1 million shares fully diluted. For further details, please visit www.mustgrow.ca.

Contact Information

MustGrow Forward-Looking Statements

Certain statements included in this news release constitute "forward-looking statements" which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.

Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Examples of forward-looking statements in this news release include, among others, statements MustGrow makes regarding: the size of the market opportunity, the outcome of the Company's promotional activities, whether MustGrow's organic biofertility product will complement the Company's existing biocontrol programs in preplant soil fumigation, postharvest food preservation, and bioherbicide; the application of MustGrow's biofungicide, and the efficacy of MustGrow's technology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. as well as those risks described in more detail in MustGrow's Annual Information Form for the year ended December 31, 2023 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available at www.sedar.com. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.

This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.

Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.

© 2024 MustGrow Biologics Corp. All rights reserved.